Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)
about
3,4-methylenedioxymethamphetamine (MDMA): current perspectivesMephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake ratsLost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humansCritical role of peripheral vasoconstriction in fatal brain hyperthermia induced by MDMA (Ecstasy) under conditions that mimic human drug useHow Postmortem Redistribution of MDMA in Acute Alcohol-MDMA Combined-Use Rats Change under Effects of Alcohol.The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the ratNonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.Cellular mechanisms in mitral valve disease.Inhibition of mirtazapine metabolism by Ecstasy (MDMA) in isolated perfused rat liver model.Key interindividual determinants in MDMA pharmacodynamics.Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation.Neurochemical binding profiles of novel indole and benzofuran MDMA analogues.Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans.
P2860
Q24602762-9D315B16-4B73-4560-9F21-9AD0973FDF63Q24617723-2DB5FB40-0A1C-4467-95E9-EC314250787EQ26859367-27A207FD-98D4-421A-A23E-5355328A27D3Q33707843-EA808EBD-7E1B-4441-BF5D-92B9ACF1C334Q33826381-E55C1D0C-2D02-4473-8C62-030BA24D9376Q34025177-A0FC2100-CB62-4C2C-8E78-6B00BF4C3F3AQ34391195-D9791241-E2A9-4B20-88E7-2F0D93E61C8EQ35142554-36766C87-F982-48E9-8E5C-61DBCA83BC86Q37422671-F2BD017D-5682-45DB-89D3-6EC816EA4C3CQ37926555-194EFB07-1AB2-48AE-8C70-6DA831429C0DQ41007402-17F80458-7AE8-4382-92B4-EFA60725A263Q47206849-08F719C3-AFDC-4C6C-BAD3-C6818CCC894EQ49373138-C2FF8DC7-3067-45AB-AF51-C755C5C3AF8BQ51482161-38B31850-3AEF-40DC-A751-C5E4A45A4F46Q51482811-716AA3A6-2303-4039-B290-EFEDE0E4FCFC
P2860
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)
@ast
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)
@en
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)
@nl
type
label
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)
@ast
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)
@en
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)
@nl
prefLabel
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)
@ast
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)
@en
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)
@nl
P2860
P1476
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)
@en
P2093
Michael H Baumann
Richard B Rothman
P2860
P304
P356
10.1016/S0074-7742(09)88010-0
P407
P577
2009-01-01T00:00:00Z